How big is the molecular influenza diagnostic market?

Buyers of the report can access verified and reliable market forecasts including those for the overall size of the global Molecular Influenza Diagnostic market in terms of revenue.On the whole the report proves to be an effective tool that players can use to ga.Molecularassays are a new type ofmolecular influenza diagnostic testto detectinfluenzaviral RNA or nucleic acids in upper respiratory tract specimens in approximately 1530 minutes.Market Analysis and Insights Global Molecular Influenza Diagnostic MarketThe global Molecular Influenza Diagnostic market size is projected to reach US XX million by 2027 from US XX million in 2020 at a CAGR of XX during 20212027.With industrystandard accuracy in analysis and high data integrity the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Influenza Diagnostic market to help players in achieving a strong market position.

Global Molecular Influenza Diagnostic Market Size, Status and Forecast 2021-2027

Code: QYRE-Auto-34T5681

Report

July 2021

Pages:108

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Abbott (Include Alere)

Molecular Assays Market

Molecular assays are a new type of molecular influenza diagnostic test to detect influenza viral RNA or nucleic acids in upper respiratory tract specimens in approximately 15-30 minutes.

The global Molecular Influenza Diagnostic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Influenza Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Influenza Diagnostic market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Influenza Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Influenza Diagnostic market.

Molecular Influenza Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Molecular Influenza Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

By Type

Reverse Transcription Polymerase Chain Reaction (RT-PCR)
Nucleic Acid Sequence Based Amplification (NASBA) Tests
Loop-mediated Isothermal Amplification-Based Assays (LAMP)
Simple Amplification-based Assays (SAMBA)

By Application

Hospitals
POCT
Others

By Region

North America
US.
Canada
Europe
Germany
France
UK.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Companies

BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific

FEATURED COMPANIES

Abbott (Include Alere)

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Molecular Influenza Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027

1.2.2 Reverse Transcription Polymerase Chain Reaction (RT-PCR)

1.2.3 Nucleic Acid Sequence Based Amplification (NASBA) Tests

1.2.4 Loop-mediated Isothermal Amplification-Based Assays (LAMP)

1.2.5 Simple Amplification-based Assays (SAMBA)

1.3 Market by Application

1.3.1 Global Molecular Influenza Diagnostic Market Share by Application: 2016 VS 2021 VS 2027

1.3.2 Hospitals

1.3.3 POCT

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Molecular Influenza Diagnostic Market Perspective (2016-2027)

2.2 Molecular Influenza Diagnostic Growth Trends by Regions

2.2.1 Molecular Influenza Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027

2.2.2 Molecular Influenza Diagnostic Historic Market Share by Regions (2016-2021)

2.2.3 Molecular Influenza Diagnostic Forecasted Market Size by Regions (2022-2027)

2.3 Molecular Influenza Diagnostic Industry Dynamic

2.3.1 Molecular Influenza Diagnostic Market Trends

2.3.2 Molecular Influenza Diagnostic Market Drivers

2.3.3 Molecular Influenza Diagnostic Market Challenges

2.3.4 Molecular Influenza Diagnostic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Molecular Influenza Diagnostic Players by Revenue

3.1.1 Global Top Molecular Influenza Diagnostic Players by Revenue (2016-2021)

3.1.2 Global Molecular Influenza Diagnostic Revenue Market Share by Players (2016-2021)

3.2 Global Molecular Influenza Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Players Covered: Ranking by Molecular Influenza Diagnostic Revenue

3.4 Global Molecular Influenza Diagnostic Market Concentration Ratio

3.4.1 Global Molecular Influenza Diagnostic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Molecular Influenza Diagnostic Revenue in 2020

3.5 Molecular Influenza Diagnostic Key Players Head office and Area Served

3.6 Key Players Molecular Influenza Diagnostic Product Solution and Service

3.7 Date of Enter into Molecular Influenza Diagnostic Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Molecular Influenza Diagnostic Breakdown Data by Type

4.1 Global Molecular Influenza Diagnostic Historic Market Size by Type (2016-2021)

4.2 Global Molecular Influenza Diagnostic Forecasted Market Size by Type (2022-2027)

5 Molecular Influenza Diagnostic Breakdown Data by Application

5.1 Global Molecular Influenza Diagnostic Historic Market Size by Application (2016-2021)

5.2 Global Molecular Influenza Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America

6.1 North America Molecular Influenza Diagnostic Market Size (2016-2027)

6.2 North America Molecular Influenza Diagnostic Market Size by Type

6.2.1 North America Molecular Influenza Diagnostic Market Size by Type (2016-2021)

6.2.2 North America Molecular Influenza Diagnostic Market Size by Type (2022-2027)

6.2.3 North America Molecular Influenza Diagnostic Market Size by Type (2016-2027)

6.3 North America Molecular Influenza Diagnostic Market Size by Application

6.3.1 North America Molecular Influenza Diagnostic Market Size by Application (2016-2021)

6.3.2 North America Molecular Influenza Diagnostic Market Size by Application (2022-2027)

6.3.3 North America Molecular Influenza Diagnostic Market Size by Application (2016-2027)

6.4 North America Molecular Influenza Diagnostic Market Size by Country

6.4.1 North America Molecular Influenza Diagnostic Market Size by Country (2016-2021)

6.4.2 North America Molecular Influenza Diagnostic Market Size by Country (2022-2027)

6.4.3 United States

6.4.4 Canada

7 Europe

7.1 Europe Molecular Influenza Diagnostic Market Size (2016-2027)

7.2 Europe Molecular Influenza Diagnostic Market Size by Type

7.2.1 Europe Molecular Influenza Diagnostic Market Size by Type (2016-2021)

7.2.2 Europe Molecular Influenza Diagnostic Market Size by Type (2022-2027)

7.2.3 Europe Molecular Influenza Diagnostic Market Size by Type (2016-2027)

7.3 Europe Molecular Influenza Diagnostic Market Size by Application

7.3.1 Europe Molecular Influenza Diagnostic Market Size by Application (2016-2021)

7.3.2 Europe Molecular Influenza Diagnostic Market Size by Application (2022-2027)

7.3.3 Europe Molecular Influenza Diagnostic Market Size by Application (2016-2027)

7.4 Europe Molecular Influenza Diagnostic Market Size by Country

7.4.1 Europe Molecular Influenza Diagnostic Market Size by Country (2016-2021)

7.4.2 Europe Molecular Influenza Diagnostic Market Size by Country (2022-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic

8 Asia-Pacific

8.1 Asia-Pacific Molecular Influenza Diagnostic Market Size (2016-2027)

8.2 Asia-Pacific Molecular Influenza Diagnostic Market Size by Type

8.2.1 Asia-Pacific Molecular Influenza Diagnostic Market Size by Type (2016-2021)

8.2.2 Asia-Pacific Molecular Influenza Diagnostic Market Size by Type (2022-2027)

8.2.3 Asia-Pacific Molecular Influenza Diagnostic Market Size by Type (2016-2027)

8.3 Asia-Pacific Molecular Influenza Diagnostic Market Size by Application

8.3.1 Asia-Pacific Molecular Influenza Diagnostic Market Size by Application (2016-2021)

8.3.2 Asia-Pacific Molecular Influenza Diagnostic Market Size by Application (2022-2027)

8.3.3 Asia-Pacific Molecular Influenza Diagnostic Market Size by Application (2016-2027)

8.4 Asia-Pacific Molecular Influenza Diagnostic Market Size by Region

8.4.1 Asia-Pacific Molecular Influenza Diagnostic Market Size by Region (2016-2021)

8.4.2 Asia-Pacific Molecular Influenza Diagnostic Market Size by Region (2022-2027)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Molecular Influenza Diagnostic Market Size (2016-2027)

9.2 Latin America Molecular Influenza Diagnostic Market Size by Type

9.2.1 Latin America Molecular Influenza Diagnostic Market Size by Type (2016-2021)

9.2.2 Latin America Molecular Influenza Diagnostic Market Size by Type (2022-2027)

9.2.3 Latin America Molecular Influenza Diagnostic Market Size by Type (2016-2027)

9.3 Latin America Molecular Influenza Diagnostic Market Size by Application

9.3.1 Latin America Molecular Influenza Diagnostic Market Size by Application (2016-2021)

9.3.2 Latin America Molecular Influenza Diagnostic Market Size by Application (2022-2027)

9.3.3 Latin America Molecular Influenza Diagnostic Market Size by Application (2016-2027)

9.4 Latin America Molecular Influenza Diagnostic Market Size by Country

9.4.1 Latin America Molecular Influenza Diagnostic Market Size by Country (2016-2021)

9.4.2 Latin America Molecular Influenza Diagnostic Market Size by Country (2022-2027)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Molecular Influenza Diagnostic Market Size (2016-2027)

10.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Type

10.2.1 Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2016-2021)

10.2.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2022-2027)

10.2.3 Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2016-2027)

10.3 Middle East & Africa Molecular Influenza Diagnostic Market Size by Application

10.3.1 Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2016-2021)

10.3.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2022-2027)

10.3.3 Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2016-2027)

10.4 Middle East & Africa Molecular Influenza Diagnostic Market Size by Country

10.4.1 Middle East & Africa Molecular Influenza Diagnostic Market Size by Country (2016-2021)

10.4.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Country (2022-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 BD

11.1.1 BD Company Details

11.1.2 BD Business Overview

11.1.3 BD Molecular Influenza Diagnostic Introduction

11.1.4 BD Revenue in Molecular Influenza Diagnostic Business (2016-2021)

11.1.5 BD Recent Development

11.2 Abbott (Include Alere)

11.2.1 Abbott (Include Alere) Company Details

11.2.2 Abbott (Include Alere) Business Overview

11.2.3 Abbott (Include Alere) Molecular Influenza Diagnostic Introduction

11.2.4 Abbott (Include Alere) Revenue in Molecular Influenza Diagnostic Business (2016-2021)

11.2.5 Abbott (Include Alere) Recent Development

11.3 Roche

11.3.1 Roche Company Details

11.3.2 Roche Business Overview

11.3.3 Roche Molecular Influenza Diagnostic Introduction

11.3.4 Roche Revenue in Molecular Influenza Diagnostic Business (2016-2021)

11.3.5 Roche Recent Development

11.4 SIEMENS

11.4.1 SIEMENS Company Details

11.4.2 SIEMENS Business Overview

11.4.3 SIEMENS Molecular Influenza Diagnostic Introduction

11.4.4 SIEMENS Revenue in Molecular Influenza Diagnostic Business (2016-2021)

11.4.5 SIEMENS Recent Development

11.5 Analytik Jena

11.5.1 Analytik Jena Company Details

11.5.2 Analytik Jena Business Overview

11.5.3 Analytik Jena Molecular Influenza Diagnostic Introduction

11.5.4 Analytik Jena Revenue in Molecular Influenza Diagnostic Business (2016-2021)

11.5.5 Analytik Jena Recent Development

11.6 Quidel

11.6.1 Quidel Company Details

11.6.2 Quidel Business Overview

11.6.3 Quidel Molecular Influenza Diagnostic Introduction

11.6.4 Quidel Revenue in Molecular Influenza Diagnostic Business (2016-2021)

11.6.5 Quidel Recent Development

11.7 Thermo Fisher

11.7.1 Thermo Fisher Company Details

11.7.2 Thermo Fisher Business Overview

11.7.3 Thermo Fisher Molecular Influenza Diagnostic Introduction

11.7.4 Thermo Fisher Revenue in Molecular Influenza Diagnostic Business (2016-2021)

11.7.5 Thermo Fisher Recent Development

11.8 Meridian Bioscience

11.8.1 Meridian Bioscience Company Details

11.8.2 Meridian Bioscience Business Overview

11.8.3 Meridian Bioscience Molecular Influenza Diagnostic Introduction

11.8.4 Meridian Bioscience Revenue in Molecular Influenza Diagnostic Business (2016-2021)

11.8.5 Meridian Bioscience Recent Development

11.9 BioMerieux

11.9.1 BioMerieux Company Details

11.9.2 BioMerieux Business Overview

11.9.3 BioMerieux Molecular Influenza Diagnostic Introduction

11.9.4 BioMerieux Revenue in Molecular Influenza Diagnostic Business (2016-2021)

11.9.5 BioMerieux Recent Development

11.10 Sekisui Diagnostics

11.10.1 Sekisui Diagnostics Company Details

11.10.2 Sekisui Diagnostics Business Overview

11.10.3 Sekisui Diagnostics Molecular Influenza Diagnostic Introduction

11.10.4 Sekisui Diagnostics Revenue in Molecular Influenza Diagnostic Business (2016-2021)

11.10.5 Sekisui Diagnostics Recent Development

11.11 Response Biomedical

11.11.1 Response Biomedical Company Details

11.11.2 Response Biomedical Business Overview

11.11.3 Response Biomedical Molecular Influenza Diagnostic Introduction

11.11.4 Response Biomedical Revenue in Molecular Influenza Diagnostic Business (2016-2021)

11.11.5 Response Biomedical Recent Development

11.12 SA Scientific

11.12.1 SA Scientific Company Details

11.12.2 SA Scientific Business Overview

11.12.3 SA Scientific Molecular Influenza Diagnostic Introduction

11.12.4 SA Scientific Revenue in Molecular Influenza Diagnostic Business (2016-2021)

11.12.5 SA Scientific Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Abbott (Include Alere)

List of Tables

Table 1. Global Molecular Influenza Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027

Table 2. Key Players of Reverse Transcription Polymerase Chain Reaction (RT-PCR)

Table 3. Key Players of Nucleic Acid Sequence Based Amplification (NASBA) Tests

Table 4. Key Players of Loop-mediated Isothermal Amplification-Based Assays (LAMP)

Table 5. Key Players of Simple Amplification-based Assays (SAMBA)

Table 6. Global Molecular Influenza Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027

Table 7. Global Molecular Influenza Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027

Table 8. Global Molecular Influenza Diagnostic Market Size by Regions (2016-2021) & (US$ Million)

Table 9. Global Molecular Influenza Diagnostic Market Share by Regions (2016-2021)

Table 10. Global Molecular Influenza Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)

Table 11. Global Molecular Influenza Diagnostic Market Share by Regions (2022-2027)

Table 12. Molecular Influenza Diagnostic Market Trends

Table 13. Molecular Influenza Diagnostic Market Drivers

Table 14. Molecular Influenza Diagnostic Market Challenges

Table 15. Molecular Influenza Diagnostic Market Restraints

Table 16. Global Molecular Influenza Diagnostic Revenue by Players (2016-2021) & (US$ Million)

Table 17. Global Molecular Influenza Diagnostic Market Share by Players (2016-2021)

Table 18. Global Top Molecular Influenza Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Influenza Diagnostic as of 2020)

Table 19. Ranking of Global Top Molecular Influenza Diagnostic Companies by Revenue (US$ Million) in 2020

Table 20. Global 5 Largest Players Market Share by Molecular Influenza Diagnostic Revenue (CR5 and HHI) & (2016-2021)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Molecular Influenza Diagnostic Product Solution and Service

Table 23. Date of Enter into Molecular Influenza Diagnostic Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Molecular Influenza Diagnostic Market Size by Type (2016-2021) (US$ Million)

Table 26. Global Molecular Influenza Diagnostic Revenue Market Share by Type (2016-2021)

Table 27. Global Molecular Influenza Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 28. Global Molecular Influenza Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)

Table 29. Global Molecular Influenza Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)

Table 30. Global Molecular Influenza Diagnostic Revenue Market Share by Application (2016-2021)

Table 31. Global Molecular Influenza Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 32. Global Molecular Influenza Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)

Table 33. North America Molecular Influenza Diagnostic Market Size by Type (2016-2021) (US$ Million)

Table 34. North America Molecular Influenza Diagnostic Market Size by Type (2022-2027) & (US$ Million)

Table 35. North America Molecular Influenza Diagnostic Market Size by Application (2016-2021) (US$ Million)

Table 36. North America Molecular Influenza Diagnostic Market Size by Application (2022-2027) & (US$ Million)

Table 37. North America Molecular Influenza Diagnostic Market Size by Country (2016-2021) & (US$ Million)

Table 38. North America Molecular Influenza Diagnostic Market Size by Country (2022-2027) & (US$ Million)

Table 39. Europe Molecular Influenza Diagnostic Market Size by Type (2016-2021) (US$ Million)

Table 40. Europe Molecular Influenza Diagnostic Market Size by Type (2022-2027) & (US$ Million)

Table 41. Europe Molecular Influenza Diagnostic Market Size by Application (2016-2021) (US$ Million)

Table 42. Europe Molecular Influenza Diagnostic Market Size by Application (2022-2027) & (US$ Million)

Table 43. Europe Molecular Influenza Diagnostic Market Size by Country (2016-2021) & (US$ Million)

Table 44. Europe Molecular Influenza Diagnostic Market Size by Country (2022-2027) & (US$ Million)

Table 45. Asia-Pacific Molecular Influenza Diagnostic Market Size by Type (2016-2021) (US$ Million)

Table 46. Asia-Pacific Molecular Influenza Diagnostic Market Size by Type (2022-2027) & (US$ Million)

Table 47. Asia-Pacific Molecular Influenza Diagnostic Market Size by Application (2016-2021) (US$ Million)

Table 48. Asia-Pacific Molecular Influenza Diagnostic Market Size by Application (2022-2027) & (US$ Million)

Table 49. Asia-Pacific Molecular Influenza Diagnostic Market Size by Region (2016-2021) & (US$ Million)

Table 50. Asia-Pacific Molecular Influenza Diagnostic Market Size by Region (2022-2027) & (US$ Million)

Table 51. Latin America Molecular Influenza Diagnostic Market Size by Type (2016-2021) (US$ Million)

Table 52. Latin America Molecular Influenza Diagnostic Market Size by Type (2022-2027) & (US$ Million)

Table 53. Latin America Molecular Influenza Diagnostic Market Size by Application (2016-2021) (US$ Million)

Table 54. Latin America Molecular Influenza Diagnostic Market Size by Application (2022-2027) & (US$ Million)

Table 55. Latin America Molecular Influenza Diagnostic Market Size by Country (2016-2021) & (US$ Million)

Table 56. Latin America Molecular Influenza Diagnostic Market Size by Country (2022-2027) & (US$ Million)

Table 57. Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2016-2021) (US$ Million)

Table 58. Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2022-2027) & (US$ Million)

Table 59. Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2016-2021) (US$ Million)

Table 60. Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2022-2027) & (US$ Million)

Table 61. Middle East & Africa Molecular Influenza Diagnostic Market Size by Country (2016-2021) & (US$ Million)

Table 62. Middle East & Africa Molecular Influenza Diagnostic Market Size by Country (2022-2027) & (US$ Million)

Table 63. BD Company Details

Table 64. BD Business Overview

Table 65. BD Molecular Influenza Diagnostic Product

Table 66. BD Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)

Table 67. BD Recent Development

Table 68. Abbott (Include Alere) Company Details

Table 69. Abbott (Include Alere) Business Overview

Table 70. Abbott (Include Alere) Molecular Influenza Diagnostic Product

Table 71. Abbott (Include Alere) Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)

Table 72. Abbott (Include Alere) Recent Development

Table 73. Roche Company Details

Table 74. Roche Business Overview

Table 75. Roche Molecular Influenza Diagnostic Product

Table 76. Roche Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)

Table 77. Roche Recent Development

Table 78. SIEMENS Company Details

Table 79. SIEMENS Business Overview

Table 80. SIEMENS Molecular Influenza Diagnostic Product

Table 81. SIEMENS Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)

Table 82. SIEMENS Recent Development

Table 83. Analytik Jena Company Details

Table 84. Analytik Jena Business Overview

Table 85. Analytik Jena Molecular Influenza Diagnostic Product

Table 86. Analytik Jena Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)

Table 87. Analytik Jena Recent Development

Table 88. Quidel Company Details

Table 89. Quidel Business Overview

Table 90. Quidel Molecular Influenza Diagnostic Product

Table 91. Quidel Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)

Table 92. Quidel Recent Development

Table 93. Thermo Fisher Company Details

Table 94. Thermo Fisher Business Overview

Table 95. Thermo Fisher Molecular Influenza Diagnostic Product

Table 96. Thermo Fisher Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)

Table 97. Thermo Fisher Recent Development

Table 98. Meridian Bioscience Company Details

Table 99. Meridian Bioscience Business Overview

Table 100. Meridian Bioscience Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)

Table 101. Meridian Bioscience Recent Development

Table 102. BioMerieux Company Details

Table 103. BioMerieux Business Overview

Table 104. BioMerieux Molecular Influenza Diagnostic Product

Table 105. BioMerieux Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)

Table 106. BioMerieux Recent Development

Table 107. Sekisui Diagnostics Company Details

Table 108. Sekisui Diagnostics Business Overview

Table 109. Sekisui Diagnostics Molecular Influenza Diagnostic Product

Table 110. Sekisui Diagnostics Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)

Table 111. Sekisui Diagnostics Recent Development

Table 112. Response Biomedical Company Details

Table 113. Response Biomedical Business Overview

Table 114. Response Biomedical Molecular Influenza Diagnostic Product

Table 115. Response Biomedical Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)

Table 116. Response Biomedical Recent Development

Table 117. SA Scientific Company Details

Table 118. SA Scientific Business Overview

Table 119. SA Scientific Molecular Influenza Diagnostic Product

Table 120. SA Scientific Revenue in Molecular Influenza Diagnostic Business (2016-2021) & (US$ Million)

Table 121. SA Scientific Recent Development

Table 122. Research Programs/Design for This Report

Table 123. Key Data Information from Secondary Sources

Table 124. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Molecular Influenza Diagnostic Market Share by Type: 2020 VS 2027

Figure 2. Reverse Transcription Polymerase Chain Reaction (RT-PCR) Features

Figure 3. Nucleic Acid Sequence Based Amplification (NASBA) Tests Features

Figure 4. Loop-mediated Isothermal Amplification-Based Assays (LAMP) Features

Figure 5. Simple Amplification-based Assays (SAMBA) Features

Figure 6. Global Molecular Influenza Diagnostic Market Share by Application: 2020 VS 2027

Figure 7. Hospitals Case Studies

Figure 8. POCT Case Studies

Figure 9. Others Case Studies

Figure 10. Molecular Influenza Diagnostic Report Years Considered

Figure 11. Global Molecular Influenza Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027

Figure 12. Global Molecular Influenza Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027

Figure 13. Global Molecular Influenza Diagnostic Market Share by Regions: 2020 VS 2027

Figure 14. Global Molecular Influenza Diagnostic Market Share by Regions (2022-2027)

Figure 15. Global Molecular Influenza Diagnostic Market Share by Players in 2020

Figure 16. Global Top Molecular Influenza Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Influenza Diagnostic as of 2020

Figure 17. The Top 10 and 5 Players Market Share by Molecular Influenza Diagnostic Revenue in 2020

Figure 18. Global Molecular Influenza Diagnostic Revenue Market Share by Type (2016-2021)

Figure 19. Global Molecular Influenza Diagnostic Revenue Market Share by Type (2022-2027)

Figure 20. North America Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 21. North America Molecular Influenza Diagnostic Market Share by Type (2016-2027)

Figure 22. North America Molecular Influenza Diagnostic Market Share by Application (2016-2027)

Figure 23. North America Molecular Influenza Diagnostic Market Share by Country (2016-2027)

Figure 24. United States Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 25. Canada Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 26. Europe Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 27. Europe Molecular Influenza Diagnostic Market Share by Type (2016-2027)

Figure 28. Europe Molecular Influenza Diagnostic Market Share by Application (2016-2027)

Figure 29. Europe Molecular Influenza Diagnostic Market Share by Country (2016-2027)

Figure 30. Germany Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 31. France Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 32. U.K. Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 33. Italy Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 34. Russia Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 35. Nordic Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 36. Asia-Pacific Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 37. Asia-Pacific Molecular Influenza Diagnostic Market Share by Type (2016-2027)

Figure 38. Asia-Pacific Molecular Influenza Diagnostic Market Share by Application (2016-2027)

Figure 39. Asia-Pacific Molecular Influenza Diagnostic Market Share by Region (2016-2027)

Figure 40. China Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 41. Japan Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 42. South Korea Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 43. Southeast Asia Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 44. India Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 45. Australia Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 46. Latin America Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 47. Latin America Molecular Influenza Diagnostic Market Share by Type (2016-2027)

Figure 48. Latin America Molecular Influenza Diagnostic Market Share by Application (2016-2027)

Figure 49. Latin America Molecular Influenza Diagnostic Market Share by Country (2016-2027)

Figure 50. Mexico Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 51. Brazil Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 52. Middle East & Africa Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 53. Middle East & Africa Molecular Influenza Diagnostic Market Share by Type (2016-2027)

Figure 54. Middle East & Africa Molecular Influenza Diagnostic Market Share by Application (2016-2027)

Figure 55. Middle East & Africa Molecular Influenza Diagnostic Market Share by Country (2016-2027)

Figure 56. Turkey Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 57. Saudi Arabia Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 58. UAE Molecular Influenza Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 59. BD Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)

Figure 60. Abbott (Include Alere) Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)

Figure 61. Roche Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)

Figure 62. SIEMENS Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)

Figure 63. Analytik Jena Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)

Figure 64. Quidel Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)

Figure 65. Thermo Fisher Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)

Figure 66. Meridian Bioscience Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)

Figure 67. BioMerieux Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)

Figure 68. Sekisui Diagnostics Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)

Figure 69. Response Biomedical Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)

Figure 70. SA Scientific Revenue Growth Rate in Molecular Influenza Diagnostic Business (2016-2021)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Molecular Influenza Diagnostic Market Size, Status and Forecast 2021-2027

Published Date: July 2021

Report Code: QYRE-Auto-34T5681

Global Molecular Influenza Diagnostic Market Size, Status and Forecast 2021-2027

FEATURED COMPANIES

Molecular Assays Market

By Type

By Application

By Region

By Companies

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-26K6048

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-20L6129

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-4F6384

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-16N6009

Mon Apr 15 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions